Genotoxin-producing Salmonella enterica induces tissue-specific types of DNA damage and DNA damage response outcomes

Front Immunol. 2024 Jan 11:14:1270449. doi: 10.3389/fimmu.2023.1270449. eCollection 2023.

Abstract

Introduction: Typhoid toxin-expressing Salmonella enterica causes DNA damage in the intestinal mucosa in vivo, activating the DNA damage response (DDR) in the absence of inflammation. To understand whether the tissue microenvironment constrains the infection outcome, we compared the immune response and DDR patterns in the colon and liver of mice infected with a genotoxigenic strain or its isogenic control strain.

Methods: In situ spatial transcriptomic and immunofluorescence have been used to assess DNA damage makers, activation of the DDR, innate immunity markers in a multiparametric analysis.

Result: The presence of the typhoid toxin protected from colonic bacteria-induced inflammation, despite nuclear localization of p53, enhanced co-expression of type-I interferons (IfnbI) and the inflammasome sensor Aim2, both classic features of DNA-break-induced DDR activation. These effects were not observed in the livers of either infected group. Instead, in this tissue, the inflammatory response and DDR were associated with high oxidative stress-induced DNA damage.

Conclusions: Our work highlights the relevance of the tissue microenvironment in enabling the typhoid toxin to suppress the host inflammatory response in vivo.

Keywords: DNA damage response; bacterial genotoxin; inflammasome; inflammation; tissue specificity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • DNA Damage
  • DNA Repair
  • Inflammation
  • Mice
  • Mutagens
  • Salmonella enterica* / genetics
  • Typhoid Fever*

Substances

  • Mutagens

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This investigation was supported by grants from the Swedish Cancer Society (20 0699 PjF), the Swedish Research Council (2021-00960), the Kempestiftelserna (SMK-1962, JCK-1826 and JCK-3110), the Cancer Research Foundation in Northern Sweden (AMP20-993 and AMP 17-884) and Umeå University to TF.